Sight Sciences, Inc.

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

SGHT$10.75-2.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(in thousands, except share and per share data)

	Three Months Ended June 30,		Six Months Ended June 30,
	2025	2024	2025	2024
Revenue	$19,564	$21,370	$37,072	$40,635
Cost of goods sold	2,977	3,025	5,391	5,819
Gross profit	16,587	18,345	31,681	34,816
Operating expenses:
Research and development	4,387	4,316	8,817	8,952
Selling, general and administrative	23,867	26,680	48,390	53,239
Total operating expenses	28,254	30,996	57,207	62,191
Loss from operations	(11,667)	(12,651)	(25,526)	(27,375)
Investment income	1,026	1,526	2,174	3,174
Interest expense	(1,284)	(1,145)	(2,547)	(2,350)
Loss on debt extinguishment	—	—	—	(1,962)
Other income (expense), net	24	(44)	(115)	(50)
Loss before income taxes	(11,901)	(12,314)	(26,014)	(28,563)
Provision for income taxes	40	15	81	32
Net loss and comprehensive loss	$(11,941)	$(12,329)	$(26,095)	$(28,595)
Net loss per share attributable to common stockholders, basic and diluted	$(0.23)	$(0.25)	$(0.51)	$(0.58)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	51,821,773	49,903,386	51,557,686	49,694,825

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.